Pediatric Systemic Lupus Erythematous in COVID-19 Era
Related Experiment Video
Updated: Aug 8, 2025

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
Published on: November 1, 2015
Ancuta Lupu1, Ingrith Crenguta Miron1, Cristina Gavrilovici1
1Pediatrics, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Insights
Pediatric systemic lupus erythematosus (SLE) patients face increased risks from COVID-19 due to immune dysfunction. This review examines the impact of COVID-19 on children with pediatric SLE.
Area of Science:
- Immunology
- Rheumatology
- Infectious Diseases
Background:
- Pediatric systemic lupus erythematosus (SLE) is a chronic autoimmune condition affecting the immune system.
- Patients with pediatric SLE often have comorbidities and are on immunosuppressive therapies.
- These factors may increase the risk of severe COVID-19 and adverse outcomes.
Purpose of the Study:
- To understand the relationship between COVID-19 and pediatric SLE.
- To analyze characteristics of newly diagnosed pediatric SLE cases post-COVID-19.
- To describe COVID-19's impact on existing pediatric SLE patients.
Main Methods:
- Literature review of reported cases.
- Analysis of newly diagnosed pediatric SLE following COVID-19.
- Examination of COVID-19's effects on established pediatric SLE cases.
Main Results:
- COVID-19 presents unique challenges for pediatric SLE patients.
- Understanding the interplay between viral infections and autoimmune diseases is crucial.
- Further research is needed to elucidate specific impacts and management strategies.
Conclusions:
- The link between COVID-19 and pediatric SLE requires further investigation.
- Pediatric SLE patients may be vulnerable to severe COVID-19 outcomes.
- This review highlights the need for tailored approaches to managing COVID-19 in this population.
Abstract:
Pediatric systemic lupus erythematosus is a chronic autoimmune disorder with a highly variable course and prognosis. It results in functional abnormalities in the immune system due to intrinsic factors and the use of immunosuppressive therapies associated with underlying comorbidities seem to increase the risk of severe COVID-19 and poor outcomes of the disease in pediatric systemic lupus erythematosus (SLE) patients. The aim of this review is to obtain a better understanding of the existing link between this new viral infection and pediatric lupus. We have analyzed the characteristics of newly diagnosed cases of pediatric SLE following COVID-19 which have been reported in the literature and which describe the impact that COVID-19 has on patients already suffering with pediatric SLE.
More Related Videos
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Nephrotic Syndrome I : Introduction
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...